Heteroplasmic mutation of mitochondrial DNA D-loop and 4977-bp deletion in human cancer cells during mitochondrial DNA depletion. 2007

Hsin-Chen Lee, and Li-Sung Hsu, and Pen-Hui Yin, and Liang-Ming Lee, and Chin-Wen Chi
Department and Institute of Pharmacology, School of Medicine, National Yang-Ming University, Taipei, Taiwan 112, Republic of China. hclee2@ym.edu.tw

Somatic mutations in mitochondrial DNA (mtDNA) have been demonstrated in various human cancers. Many cancers have high frequently of mtDNA with homoplasmic point mutations, and carry less frequently of mtDNA with large-scale deletions as compared with corresponding non-cancerous tissue. Moreover, most cancers harbor a decreased copy number of mtDNA than their corresponding non-cancerous tissue. However, it is unclear whether the process of decreasing in mtDNA content would be involved in an increase in the heteroplasmic level of somatic mtDNA point mutation, and/or involved in a decrease in the proportion of mtDNA with large-scale deletion in cancer cells. In this study, we provided evidence that the heteroplasmic levels of variations in cytidine number in np 303-309 poly C tract of mtDNA in three colon cancer cells were not changed during an ethidium bromide-induced mtDNA depleting process. In the mtDNA depleting process, the proportions of mtDNA with 4977-bp deletion in cybrid cells were not significantly altered. These results suggest that the decreasing process of mtDNA copy number per se may neither contribute to the shift of homoplasmic/heteroplasmic state of point mutation in mtDNA nor to the decrease in proportion of mtDNA with large-scale deletions in cancer cells. Mitochondrial genome instability and reduced mtDNA copy number may independently occur in human cancer.

UI MeSH Term Description Entries
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D004272 DNA, Mitochondrial Double-stranded DNA of MITOCHONDRIA. In eukaryotes, the mitochondrial GENOME is circular and codes for ribosomal RNAs, transfer RNAs, and about 10 proteins. Mitochondrial DNA,mtDNA
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D004996 Ethidium A trypanocidal agent and possible antiviral agent that is widely used in experimental cell biology and biochemistry. Ethidium has several experimentally useful properties including binding to nucleic acids, noncompetitive inhibition of nicotinic acetylcholine receptors, and fluorescence among others. It is most commonly used as the bromide. Ethidium Bromide,Homidium Bromide,Novidium,Bromide, Ethidium,Bromide, Homidium
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006822 Hybrid Cells Any cell, other than a ZYGOTE, that contains elements (such as NUCLEI and CYTOPLASM) from two or more different cells, usually produced by artificial CELL FUSION. Somatic Cell Hybrids,Cell Hybrid, Somatic,Cell Hybrids, Somatic,Cell, Hybrid,Cells, Hybrid,Hybrid Cell,Hybrid, Somatic Cell,Hybrids, Somatic Cell,Somatic Cell Hybrid
D017353 Gene Deletion A genetic rearrangement through loss of segments of DNA or RNA, bringing sequences which are normally separated into close proximity. This deletion may be detected using cytogenetic techniques and can also be inferred from the phenotype, indicating a deletion at one specific locus. Deletion, Gene,Deletions, Gene,Gene Deletions
D017354 Point Mutation A mutation caused by the substitution of one nucleotide for another. This results in the DNA molecule having a change in a single base pair. Mutation, Point,Mutations, Point,Point Mutations
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Hsin-Chen Lee, and Li-Sung Hsu, and Pen-Hui Yin, and Liang-Ming Lee, and Chin-Wen Chi
November 2004, Ai zheng = Aizheng = Chinese journal of cancer,
Hsin-Chen Lee, and Li-Sung Hsu, and Pen-Hui Yin, and Liang-Ming Lee, and Chin-Wen Chi
February 2004, Experimental gerontology,
Hsin-Chen Lee, and Li-Sung Hsu, and Pen-Hui Yin, and Liang-Ming Lee, and Chin-Wen Chi
January 2006, Indian journal of cancer,
Hsin-Chen Lee, and Li-Sung Hsu, and Pen-Hui Yin, and Liang-Ming Lee, and Chin-Wen Chi
January 1994, Archives of dermatological research,
Hsin-Chen Lee, and Li-Sung Hsu, and Pen-Hui Yin, and Liang-Ming Lee, and Chin-Wen Chi
January 1999, Mutagenesis,
Hsin-Chen Lee, and Li-Sung Hsu, and Pen-Hui Yin, and Liang-Ming Lee, and Chin-Wen Chi
January 2019, Oncology reviews,
Hsin-Chen Lee, and Li-Sung Hsu, and Pen-Hui Yin, and Liang-Ming Lee, and Chin-Wen Chi
December 2005, Molecular human reproduction,
Hsin-Chen Lee, and Li-Sung Hsu, and Pen-Hui Yin, and Liang-Ming Lee, and Chin-Wen Chi
February 2009, BMC research notes,
Hsin-Chen Lee, and Li-Sung Hsu, and Pen-Hui Yin, and Liang-Ming Lee, and Chin-Wen Chi
April 2014, Andrologia,
Hsin-Chen Lee, and Li-Sung Hsu, and Pen-Hui Yin, and Liang-Ming Lee, and Chin-Wen Chi
June 2012, Balkan journal of medical genetics : BJMG,
Copied contents to your clipboard!